Jasper Therapeutics, Inc. (JSPR) vs Kyntra Bio Inc (KYNB)
- Jasper Therapeutics, Inc. JSPR 13.68 +2.32%
- Kyntra Bio Inc KYNB 3.44 −4.18%
Jasper Therapeutics, Inc. and Kyntra Bio Inc are both Biotechnology companies. Jasper Therapeutics, Inc. and Kyntra Bio Inc are of similar size ($14.8M and $14.5M). Jasper Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Kyntra Bio Inc trades at 0.1×. Kyntra Bio Inc has the higher net margin (3,967.8% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Kyntra Bio Inc leads on 7 and Jasper Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | JSPR | KYNB | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 6.28% | 67.24% |
| Operating margin | 0.00% | (1,089.78%) | 0.00% |
| Net margin | 0.00% | 3,967.77% | 0.00% |
| Free cash flow margin | 0.00% | (824.19%) | 0.00% |
| Return on equity | (255.05%) | (157.83%) | (50.28%) |
| Return on assets | (109.05%) | 131.26% | (45.89%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack